These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7840317)

  • 1. Hemodynamic response to vasopressin during V1-receptor antagonism in baroreflex-deficient subjects.
    Huch KM; Runyan KR; Wall BM; Gavras H; Cooke CR
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R156-63. PubMed ID: 7840317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of vasopressin following V(1) receptor blockade compared to effects of nitroglycerin.
    Cooke CR; Wall BM; Huch KM; Mangold T
    Am J Physiol Regul Integr Comp Physiol; 2001 Sep; 281(3):R887-93. PubMed ID: 11507005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate.
    Luk J; Ajaelo I; Wong V; Wong J; Chang D; Chou L; Reid IA
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R524-9. PubMed ID: 8214142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin modulation of arterial baroreflex responses in fetal and newborn sheep.
    Nuyt AM; Segar JL; Holley AT; O'Mara MS; Chapleau MW; Robillard JE
    Am J Physiol; 1996 Dec; 271(6 Pt 2):R1643-53. PubMed ID: 8997365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressor dose responses and baroreflex sensitivity in quadriplegic spinal cord injury patients.
    Krum H; Louis WJ; Brown DJ; Howes LG
    J Hypertens; 1992 Mar; 10(3):245-50. PubMed ID: 1315821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous arginine vasopressin does not enhance carotid baroreflex control in the conscious dog.
    Wolfer RS; Lovell NH; Brunner MJ
    Am J Physiol; 1994 May; 266(5 Pt 2):R1510-6. PubMed ID: 8203628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasopressin V1-receptor blockade during acute and sustained hypovolemic hypotension.
    Wall BM; Huch KM; Runyan KR; Williams HH; Gavras H; Cooke CR
    Am J Physiol; 1996 Feb; 270(2 Pt 2):R356-64. PubMed ID: 8779866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of vasopressin release during controlled reduction in arterial pressure.
    Wall BM; Runyan KR; Williams HH; Bobal MA; Crofton JT; Share L; Cooke CR
    J Lab Clin Med; 1994 Oct; 124(4):554-63. PubMed ID: 7930879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of AVP.V1-receptor antagonist on urinary albumin excretion and renal hemodynamics in NIDDM nephropathy: role of AVP.V1-receptor.
    Yamada K; Nakano H; Nishimura M; Yoshida S
    J Diabetes Complications; 1995; 9(4):326-9. PubMed ID: 8573758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs.
    Kaczmarczyk G; Vogel S; Krebs M; Bünger H; Scholz A
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1396-402. PubMed ID: 8945979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. During acute hypercapnia vasopressin inhibits an angiotensin drive to ventilation in conscious dogs.
    Walker JK; Jennings DB
    J Appl Physiol (1985); 1995 Sep; 79(3):786-94. PubMed ID: 8567518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man.
    Ebert TJ; Cowley AW; Skelton M
    J Clin Invest; 1986 Apr; 77(4):1136-42. PubMed ID: 3514673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vasopressin in acutely altered baroreflex sensitivity during hemorrhage in rats.
    Brizzee BL; Russ RD; Walker BR
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R677-85. PubMed ID: 1887955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat.
    Webb RL; Osborn JW; Cowley AW
    Am J Physiol; 1986 Dec; 251(6 Pt 2):H1244-51. PubMed ID: 3789178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflex effect of vasopressin after blockade of V1 receptors in the area postrema.
    Hasser EM; Bishop VS
    Circ Res; 1990 Aug; 67(2):265-71. PubMed ID: 2376071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological arginine vasopressin levels do not enhance baroreflex function in normal humans.
    Goldsmith SR
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2374-9. PubMed ID: 8023998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of baroreceptor denervation on the inhibition of renin release by vasopressin.
    Gregory LC; Quillen EW; Keil LC; Reid IA
    Endocrinology; 1988 Jul; 123(1):319-27. PubMed ID: 3289894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
    Shimizu K; Schwartz J; McGrath BP
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R345-9. PubMed ID: 8447490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.